Arcellx, Inc. Common Stock
ACLX
XNAS
•
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market Cap
6.7B
Short interest (Apr 15)
3.1%
Net Short (Apr 27 ): 0.0%
Borrow Fee
0.25%
Available Shares
0
Price Chart
Company Overview
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Company Info
Exchange:
NASDAQ
Industry:
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK:
0001786205
Asset Type:
CS
Market Data
Market Cap:
$6,732,325,464
Employees:
209
Status:
Active
Short Interest
Current Borrow Fee
0.25%
Range: 0.25% -
0.25%
Available Shares
0
Range: 0 -
0
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.